epiberberine has been researched along with (1S,2R)-tranylcypromine in 1 studies
| Studies (epiberberine) | Trials (epiberberine) | Recent Studies (post-2010) (epiberberine) | Studies ((1S,2R)-tranylcypromine) | Trials ((1S,2R)-tranylcypromine) | Recent Studies (post-2010) ((1S,2R)-tranylcypromine) |
|---|---|---|---|---|---|
| 49 | 0 | 37 | 11 | 0 | 8 |
| Protein | Taxonomy | epiberberine (IC50) | (1S,2R)-tranylcypromine (IC50) |
|---|---|---|---|
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | 5.26 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 2.2084 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 1.22 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, R; He, X; Wang, S; Xie, T; Ye, XY; Ye, Y; Zhang, H; Zhang, Y | 1 |
1 review(s) available for epiberberine and (1S,2R)-tranylcypromine
| Article | Year |
|---|---|
Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present).
Topics: Drug Discovery; Histone Demethylases; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Structure-Activity Relationship | 2022 |